首页> 外文期刊>Bulletin of Clinical Psychopharmacology >Fluoxetine- and sertraline-related hair loss in a teenager: a case report
【24h】

Fluoxetine- and sertraline-related hair loss in a teenager: a case report

机译:青少年氟西汀和舍曲林相关脱发:病例报告

获取原文
获取外文期刊封面目录资料

摘要

Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed antidepressants. All SSRIs have occasionally been associated with alopecia or hair loss. There might be differences in the risk of alopecia between the various SSRIs, and the risk might be higher in women than in men. The pathological mechanism of hair loss due to psychotropic medications has not yet been fully elucidated. Here, we present an adolescent female with no personal and family history of alopecia, who developed common alopecia with consecutive ?uoxetine and sertraline treatments. The hair loss stopped with a venlafaxine regimen. To our knowledge, this is the first report of hair loss due to both ?uoxetine and sertraline, which then recovered with venlafaxine treatment. If a patient develops hair loss during SSRI treatment and the temporal relationship seems plausible, an adverse drug reaction should be suspected and changing the treatment to another antidepressant or possibly decreasing the dose should be considered.
机译:选择性5-羟色胺再摄取抑制剂(SSRIs)是广泛使用的抗抑郁药。所有SSRI偶尔都与脱发或脱发有关。各种SSRI之间的脱发风险可能有所不同,女性的风险可能高于男性。由于精神药物引起的脱发的病理机理尚未完全阐明。在这里,我们介绍了一位没有个人和家族脱发史的青春期女性,她们通过连续的氟西汀和舍曲林治疗而发展为普通脱发。服用文拉法辛治疗可以使脱发停止。据我们所知,这是氟西汀和舍曲林造成脱发的首例报告,随后通过文拉法辛治疗得以恢复。如果患者在SSRI治疗期间出现脱发并且时间关系似乎合理,则应怀疑药物不良反应,应考虑将治疗改为另一种抗抑郁药或可能减少剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号